CASE DISCUSSION
Fluid Management and Hemodynamic Optimization
Presented from India by Dr. Prajeesh M. Nambiar0
Likes
264966
Views
10,599
Shares
10,599
Bookmarks
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
Fluid management and hemodynamic optimization are crucial components of patient care in various clinical settings, particularly in critical care, perioperative care, and the management of sepsis and shock. The goal of fluid management is to achieve an optimal balance between fluid administration...
Case Summary
- Fluid management is a crucial aspect of inpatient medical care, especially in the ICU, with each patient having unique requirements. There is no universal formula, and fluid choices depend on electrolyte content, tonicity, and medical conditions. The two primary types of IV fluids are crystalloids (like Plasmalyte and Lactated Ringer's) and colloids (like hydroxy starch solutions). Crystalloids are typically the first-line treatment, while colloids are used when indicated, with caution due to the risk of acute kidney injury.
Speaker Profile
Dr. Prajeesh M. Nambiar
Consultant, Cardiothoracic Anesthesia and Cardiac Critical Care, Medanta the Medicity, GurgaonDr. Prajeesh M. Nambiar is a distinguished Consultant specializing in cardiac anesthesia and critical care at Medanta - the Medicity in Gurgaon. With an impressive array of qualifications including MBBS, MD, DNB, FIACTA, FICCC, FIAE, and an MBA, Dr. Nambiar brings extensive expertise to his role. He has a keen interest in cardiac critical care, trans-oesophageal echocardiography, heart and lung transplant, and mechanical circulatory support devices. Dr. Nambiar has published extensively, with 16 national and international publications to his credit. He has also enriched his experience through a transplant observer ship at prestigious institutions like Toronto General Hospital and Peter Munk Cardiac Centre in Canada.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.